Invega Dosage

For most people with schizophrenia, the starting Invega dosage is 6 mg once daily, taken in the morning. Your healthcare provider may increase your daily dose up to 12 mg if needed. People with kidney disease usually need to take a lower Invega dose, such as 3 mg once a day.

 

An Introduction to Invega Dosage

The dose of Invega® (paliperidone) your healthcare provider recommends will vary depending on a number of factors, including:
 
  • Other medical conditions you may have
  • Other medications you may be currently taking.
     
As always, do not adjust your Invega dosage unless your healthcare provider specifically instructs you to do so.
 
Invega Dosing for Schizophrenia
The recommended starting Invega dose for schizophrenia is 6 mg once daily in the morning. If needed, your healthcare provider can increase your dose up to Invega 12 mg once daily in the morning.
 
People with kidney disease may need a lower Invega dose (such as Invega 3 mg once daily).
 

General Information on Dosing With Invega

Some considerations for people taking Invega include:
 
  • Invega comes in tablet form. It is usually taken by mouth once a day in the morning.
     
  • It does not matter if you take Invega with or without food. If the medication bothers your stomach, try taking it with food.
     
  • Invega tablets are specially designed to slowly release the medication over time. They should be swallowed whole with water (or other liquids) and should not be crushed, chewed, or broken.
     
  • Invega should be taken at the same time each day to maintain even levels of the drug in your blood.
     
  • For the drug to work properly, it must be taken as prescribed. Invega will not work if you stop taking it.
     
  • If you are unsure about anything related to your dosage or Invega dosing in general, please talk with your doctor, nurse, or pharmacist. Do not stop taking Invega without first discussing it with your healthcare provider (see Invega Withdrawal).
Add this article to your Favorites     Email this article     Print
Written by/reviewed by: Kristi Monson, PharmD; Arthur Schoenstadt, MD
Last reviewed by: Kristi Monson, PharmD;